The Arora Report

February 28, 2017

TAKE PARTIAL PROFITS ON MYLAN $MYL

This post was just published on ZYX Buy Change Alert.

MYL is long from an average price of $37.78. As of this writing it is trading at $41.97. Consider taking profits on a 15% tranche in the zone of $41.23 to $44.73. Consider a stop on the remaining in the zone of $39.23 to $39.43.

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.… Please click here or the title below to read more.

February 28, 2017

BIOTECH BEAR ETF LABD: FUND MOVES INTO BIOTECHS AFTER LIQUIDATING PRECIOUS METAL STOCKS $LABD $XBI $IBB $GDX $GDXJ $DUST $NUGT

This post was just published on ZYX Buy Change Alert.

Please see the Morning Capsule for apparently a fund moving money from liquidating precious metal stocks into biotechs. This explains the move lower in LABD.

The real reason for holding is a potential Trump tweet or mention in his speech tonight of drug prices. In our analysis, the probability of Trump mentioning drug prices in tonight’s speech is low. However as the Congress moves towards repeal of Obamacare, details may have a negative impact on biotechs and pharmaceuticals.

LABD buy zone remains $9.50 to $12.52. First target remains $19.50 to $20.

… Please click here or the title below to read more.

February 28, 2017